TheraSense FreeStyle
This article was originally published in The Gray Sheet
Executive Summary
Blood glucose monitor launched Aug. 1 is "virtually pain-free," since it uses only 0.3 microliters of blood taken from the arm and obviates the need for larger fingertip blood samples, the company claims. Cleared via 510(k) in January, the device uses "less [blood] than other blood glucose monitoring systems on the market," according to the Alameda, California firm. The FreeStyle meter uses coulometric technology to minimize the needed sample size and retails for $75; test strips used with the meter are priced at $39 for 50 or $69 for 100
You may also be interested in...
US FDA Gene Therapy Accelerated Approval Guidance Will Describe ‘Buckets’ Of Use Scenarios
Forthcoming guidance is expected to describe areas of “low-hanging fruit” and those that are more challenging for use of the expedited pathway, Center for Biologics Evaluation and Research Director Peter Marks said.
FTC Early Findings In PBM Investigation Coming By Mid-Summer, Chair Kahn Says
The agency is also poised to announce another development in its scrutiny of the drug patents listed in the FDA’s Orange Book.
ImmunityBio Will Aim Anktiva At Large Share Of Bladder Cancer Market
Execs Richard Adcock and Patrick Soon-Shiong told Scrip the company sees an addressable US population of about 20,000 and is aiming for ease of physician adoption.